Drawing for Serial No. 99502866

USPTO serial 99502866

Serial No. 99502866

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
LEE, CATHERINE ANNE
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with Serial No. 99502866?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Julian Gonzalez

Julian Gonzalez Goldstein Patent Law320 Broad StRed Bank, NJ 07701United States

Goods and services

ClassDescriptionStatusFirst use
044Intravenous (IV) hydration therapy services; Intravenous (IV) vitamin therapy services; Vitamin therapy; Medical services, namely, mobile intravenous drip services; Medical services, namely, administering vitamins, minerals and electrolytes via intravenous therapy; Medical services, namely, intravenous hydration therapy, drug addiction detox, cancer treatment support, high dose vitamin C delivery, all through intravenous therapy; Medical services, namely, intravenous nutrition and removing of metals and toxins from the body through chelation therapy; Medical services, namely, alleviating symptoms of hangover, alleviating symptoms of chemo therapy and radiation therapy used for cancer clients with high dose vitamin C, through intravenous therapy; Medical services, namely, sharpening brain activity, and hormone replacement therapy for those with decreased levels of testosterone and to raise HcG levels, through intravenous therapy; Medical services, namely, fighting exhaustion and enhancing concentration and focus levels through intravenous therapy; Medical services, namely, fighting fatigue, anxiety, depression, insomnia and poor sleep quality through intravenous therapy; Medical services, namely, rejuvenating body and fighting effects of aging through intravenous therapy; Medical services, namely, alleviating inflammation, muscle pain, fatigue, anxiety and stress, through intravenous therapy; Medical services, namely, improving immune health and mental clarity by providing vitamins, antioxidants, and hydration through intravenous therapy; Medical services, namely, cleansing the body and removing toxins through intravenous therapy; Medical services, namely, providing vitamin and mineral booster shots in order to boost energy, focus, metabolism, and immune system, all through intravenous therapy; Medical services, namely, performing non-invasive cosmetic medical procedures such as providing botulinum toxin injections and injectable fillers; Medical services, namely, administering customized intravenous therapy consisting of nutrients and replenishing fluids administered to patients by healthcare professionals for the prevention and treatment of medical symptoms and conditions; Medical services, namely, providing fluids, vitamins and amino acids in order to boost metabolism, detoxify the body and burn fat, all through intravenous therapy and intramuscular injections; Medical services, namely, administering customized intramuscular injections of nutrients and replenishing fluids administered to patients by healthcare professionals for the prevention and treatment of medical symptoms and conditions; Medical services, namely, rejuvenating body and fighting effects of aging through intravenous therapy and intramuscular injections; Medical services, namely, providing weight loss medications through subcutaneous injections; Hydrotherapy services for injecting fluids, vitamins, antioxidants, electrolytes, amino acids, and medications for symptomatic relief of dehydration, exhaustion, nausea, hangovers, and pain; Health spa services for health and wellness of the body and spirit; Health care services, namely, intravenous therapy, vitamin therapy; Home health care services, namely, mobile intravenous drip services; Home health care services, namely, intravenous therapy, vitamin therapy; Home health care services, namely, administering customized intravenous therapy consisting of nutrients and replenishing fluids administered to patients by healthcare professionals for the prevention and treatment of medical symptoms and conditions; Home health care services, namely, providing fluids, vitamins and amino acids in order to boost metabolism, detoxify the body and burn fat, all through intravenous therapy and intramuscular injections; Home health care services, namely, administering customized intramuscular injections of nutrients and replenishing fluids administered to patients by healthcare professionals for the prevention and treatment of medical symptoms and conditions; Home health care services, namely, rejuvenating body and fighting effects of aging through intravenous therapy and intramuscular injections; Home health care services, namely, providing weight loss medications through subcutaneous injectionsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 6, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 6, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 30, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 10, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 3, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 3, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 3, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 24, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jun 24, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
Mar 27, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 27, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 25, 2026DOCKASSIGNED TO EXAMINER—
Mar 20, 2026MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Mar 20, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 18, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 18, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance